Avanir layoffs, Otsuka next?

Discussion in 'Otsuka' started by anonymous, Jan 18, 2020 at 8:54 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest


  2. anonymous

    anonymous Guest

    Insider here...Otsuka has way too many reps, red team, blue team, ready-now. This business model is simply not sustainable in these times of declining access. Just look at the salaries and associated costs of reps and DMs in relation to new prescribers created...it’s ridiculous...Add to that the political climate about drug prices in Washington and I guarantee you that Otsuka will act swiftly to cut costs if necessary. Lastly, look at the product life cycle of what we promote and the writing is on the wall.

    Other companies are reacting already proactively...that is just not in Otsuka’s DNA.

    As a result, when changes will be inevitably made, they will be more drastic...
    Even good performers won’t be safe. It has happened time and time again...